Абишев, А. Т. (2020). Анализ состояния дерматовенерологической службы Республики Казахстан по итогам 2020 года. Вопросы дерматологии и Венерологии (1-2), 29-36.
azattyq.org. (15 07 2021 г.). Получено из Метадон: зло или благо? Что будет с заместительной терапией для наркозависимых. Accessed on 10.08.2021 via
https://rus.azattyq.org/a/kazakhstan-methadone-drug-addiction-treatment-project/31356654.html
akzhol.kz. (24 05 2017 г.). Почему наркотик «Метадон», запрещенный Конвенцией ООН к применению в медицинских целях, официально используется у нас в качестве препарата заместительной терапии? Получено из Официальный сайт Демократической партии «Ак- жол». Accessed on 01.09.2021 via https://akzhol.kz/ru/migrated_4694/
cisc.kz. ПРОЕКТЫ НАО Центр поддержки гражданских инициатив. Получено из НАО Центр поддержки гражданских инициатив. Accessed on 21.06.2021 via https://cisc.kz/ru/projects/?_projects_theme=6c05744a6ba3f84c21334f66f2e16521
Chen, T., & Zhao, M. (2019). Meeting the challenges of opioid dependence in China: Experience of opioid agonist treatment. In Current Opinion in Psychiatry (Vol. 32, Issue 4, pp. 282–287). Lippincott Williams and Wilkins. https://doi.org/10.1097/YCO.0000000000000509
Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., Cepeda, J., Comfort, M., Goosby, E., Goulão, J., Hart, C., Kerr, T., Lajous, A. M., Lewis, S., Martin, N., Mejía, D., Camacho, A., Mathieson, D., Obot, I., … Beyrer, C. (2016). Public health and international drug policy. The Lancet, 387(10026), 1427–1480. https://doi.org/10.1016/S0140-6736(16)00619-X
Dong, R., Wang, H., Li, D., Lang, L., Gray, F., Liu, Y., Laffont, C. M., Young, M., Jiang, J., Liu, Z., & Learned, S. M. (2019). Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder. Drugs in R and D, 19(3), 255–265. https://doi.org/10.1007/s40268-019-0277-9
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2021). Balancing access to opioid substitution treatment with preventing the diversion of opioid substitution medications in Europe: challenges and implications (Issue February). https://www.emcdda.europa.eu/publications/technical-reports/opioid-substitution-treatment-ost-in-europe-availability-and-diversion_en
Harm Reduction International. (2014). The Global State of Harm Reduction 2014 (K. A. Stone (ed.)). Harm Reduction International.
Hedrich, D., Pirona, A., & Wiessing, L. (2008). From margin to mainstream: The evolution of harm reduction responses to problem drug use in Europe. Drugs: Education, Prevention and Policy, 15(6), 503–517. https://doi.org/10.1080/09687630802227673
Hieromonakh, A.V., Shvetsova, Y.B., & Kaklyugin, N.V. (2007). ОСТОРОЖНО – МЕТАДОН!!! Accessed on 01.09.2021 via http://www.blaivus.org/UserFiles/blaivi_karta/14.3.%20Pakaitinis%20gydymas%20metadonu/539atsargiai4.pdf
informburo.kz. (11 06 2017 г.). Получено 2021, из Пункт бесплатной выдачи метадона откроют в наркодиспансере Атырау:
https://informburo.kz/novosti/punkt-besplatnoy-vydachi-metadona-otkroyut-v-narkodispansere-atyrau.html
LaMonaca, K., Dumchev, K., Dvoriak, S., Azbel, L., Morozova, O., & Altice, F. L. (2019). HIV, Drug Injection, and Harm Reduction Trends in Eastern Europe and Central Asia: Implications for International and Domestic Policy. In Current Psychiatry Reports (Vol. 21, Issue 7). Current Medicine Group LLC 1. https://doi.org/10.1007/s11920-019-1038-8
Latypov, A. (2010). Opioid substitution therapy in Tajikistan: Another perpetual pilot? International Journal of Drug Policy, 21(5), 407–410. https://doi.org/10.1016/j.drugpo.2010.01.013
Latypov, A., Otiashvili, D., Aizberg, O., & Boltaev, A. (2010). Opioid Substitution Therapy in Central Asia: Towards diverse and effective treatment options for drug dependence.
Lee, S., & Newman, R. (2017). Methadone maintenance — lessons from two systems in China. Harm Reduction Journal, 14(66), 1–5. https://doi.org/10.1186/s12954-017-0193-7
Lucas, G. M., Beauchamp, G., Aramrattana, A., Shao, Y., Liu, W., Fu, L., Jackson, J. B., Celentano, D. D., Richardson, P., & Metzger, D. (2012). Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058. International Journal of Drug Policy, 23(2), 162–165. https://doi.org/10.1016/j.drugpo.2011.06.005
Marienfeld, C., Liu, P., Wang, X., Schottenfeld, R., Zhou, W., & Chawarski, M. C. (2017). Evaluation of an implementation of methadone maintenance treatment in China. Physiology & Behavior, 176(12), 139–148. https://doi.org/10.1016/j.drugalcdep.2015.10.001.Evaluation
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. In Cochrane Database of Systematic Reviews (Vol. 2009, Issue 3). John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD002209.pub2
mk-kz.kz. (12 07 2019 г.). «МК в Казахстане». Получено 2021, из Метадон для наркозависимых: благо или зло?. Accessed on 17.08.2021 via https://mk-kz.kz/social/2019/07/12/metadon-dlya-narkozavisimykh-blago-ili-zlo.html
National Institute on Drug Abuse (NIDA). (2021). Words Matter: Terms to Use and Avoid When Talking About Addiction. NIDAMED. https://www.drugabuse.gov/nidamed-medical-health-professionals/health-professions-education/words-matter-terms-to-use-avoid-when-talking-about-addiction
Parsons, D., Burrows, D., & Bolotbaeva, A. (2014). Advocating for opioid substitution therapy in Central Asia: Much still to be done. International Journal of Drug Policy, 25(6), 1174–1177. https://doi.org/10.1016/j.drugpo.2014.01.004
Schulte, M., Liang, D., Wu, F., Lan, Y.-C., Tsay, W., Du, J., Zhao, M., Li, X., & Hser, Y. (2017). A smartphone application supporting recovery from heroin addiction: Perspectives of patients and providers in China, Taiwan, and the USA. Physiology & Behavior, 176(3), 139–148. https://doi.org/10.1007/s11481-016-9653-1.A
Serebryakova, L., Cook, C., & Davies, C. (2021). Failure to fund: The continued crisis for harm reduction funding in low-and middle-income countries (Issue May).
Shen, W., Wang, Q., Zhang, J., Ping, W., Zhang, J., Ye, W., Hu, Q., Cerci, D., & Zhou, W. (2019). A Retrospective Survey of Buprenorphine Substitute Treatment With Minimal Dosage in Heroin Use Disorder. Frontiers in Psychiatry, 10(December), 1–8. https://doi.org/10.3389/fpsyt.2019.00888
Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ (Clinical Research Ed.), 357, j1550. https://doi.org/10.1136/bmj.j1550
Sullivan, S. G., Wu, Z., Cao, X., Liu, E., & Detels, R. (2014). Continued drug use during methadone treatment in China: A retrospective analysis of 19,026 service users. J Subst Abuse Treat, 47(1), 86–92. https://doi.org/10.1016/j.jsat.2013.12.004.Continued
United Nations Office on Drugs and Crime. (2020). World Drug Report. www.unodc.org/wdr2020
Wang, L., Wei, X., Wang, X., Li, J., Li, H., & Jia, W. (2014). Long-term effects of methadone maintenance treatment with different psychosocial intervention models. PLoS ONE, 9(2), 1–8. https://doi.org/10.1371/journal.pone.0087931
World Health Organization. (2009). Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. In Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. http://www.who.int/substance_abuse/publications/opioid_dependence_guidelines.pdf
World Health Organization. (2014). How to improve Opioid Substitution Therapy implementation: Experiences from EU countries, part of a join EAHC-WHO project involving Bulgaria, Estonia, Germany, Latvia, Lithuania, Poland, Portugal and Romania (Issue January). http://www.euro.who.int/__data/assets/pdf_file/0015/241341/How-to-improve-Opioid-Substitution-Therapy-implementation.pdf?ua=1:
Yan, L., Liu, E., McGoogan, J. M., Duan, S., Wu, L. T., Comulada, S., & Wu, Z. (2013). Referring heroin users from compulsory detoxification centers to community methadone maintenance treatment: A comparison of three models. BMC Public Health, 13(1), 1–8. https://doi.org/10.1186/1471-2458-13-747
Zabransky, T., Mravcik, V., Talu, A., & Jasaitis, E. (2014). Post-Soviet Central Asia: A summary of the drug situation. International Journal of Drug Policy, 25(6), 1186–1194. https://doi.org/10.1016/j.drugpo.2014.05.004
zakon.kz. (n.d.). Получено из Граждане Казахстана выступают против продвижения наркотика «метадон», как средства для «лечения» наркозависимых. Accessed August 29, 2021 via https://online.zakon.kz/Document/?doc_id=30955906#pos=19;-12
Zhang, L., Bao, J., Harrington, A., Fan, X., Ning, Z., Zhang, J., Shi, D., Hu, M., Zhou, Z., Cai, Z., Zhao, M., & Du, J. (2019). Mixed methods to explore factors associated with the decline of patients in the methadone maintenance treatment program in Shanghai, China. Harm Reduction Journal, 16(34), 1–7.